As drug industry’s influence over research grows, so does th

Moderators: Elvis, DrVolin, Jeff

As drug industry’s influence over research grows, so does th

Postby harry ashburn » Mon Nov 26, 2012 1:33 pm

(Multi-page article, click link for whole thing)
http://www.washingtonpost.com/business/ ... ml?hpid=z1

As drug industry’s influence over research grows, so does the potential for bias

By Peter Whoriskey,
Nov 25, 2012 01:45 AM EST

The Washington Post Published: November 24
For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup.

The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.

“We now have clear evidence from a large international study that the initial use of [Avandia] is more effective than standard therapies,” a senior vice president of GlaxoSmithKline, Lawson Macartney, said in a news release.

What only careful readers of the article would have gleaned is the extent of the financial connections between the drugmaker and the research. The trial had been funded by GlaxoSmithKline, and each of the 11 authors had received money from the company. Four were employees and held company stock. The other seven were academic experts who had received grants or consultant fees from the firm.
A skeleton walks into a bar. Orders a beer, and a mop. -anon
harry ashburn
 
Posts: 289
Joined: Tue Nov 15, 2011 7:13 pm
Blog: View Blog (0)

Return to Health

Who is online

Users browsing this forum: No registered users and 1 guest